Loss of Kv and MaxiK currents associated with increased MRP1 expression in small cell lung carcinoma

Journal of Cellular Physiology

Volumn 209, Issue 2, 2006, Pages 535-541

  Lam, Hung D ^a   Lemay, Anne Marie ^a   Kelly, Jackie ^a   Hill, Ceredwyn E ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b HOTEL DIEU HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; GLUCONATE POTASSIUM; IBERIOTOXIN; INWARDLY RECTIFYING POTASSIUM CHANNEL; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; ORGANIC ANION TRANSPORTER; POTASSIUM; POTASSIUM CHANNEL;

ANION EXCHANGE; ARTICLE; CELL LINE; CELL MEMBRANE POTENTIAL; CELL TYPE; CONTROLLED STUDY; ELECTRIC POTENTIAL; EXOCRINE SECRETION; GENE EXPRESSION; HUMAN; HUMAN CELL; ION CONDUCTANCE; ION CURRENT; KV CURRENT; LUNG SMALL CELL CANCER; MAXIK CURRENT; NUCLEOTIDE SEQUENCE; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME;

CALCIUM; CARCINOMA, SMALL CELL; ELECTRIC CONDUCTIVITY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; LUNG NEOPLASMS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PEPTIDES; POTASSIUM; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 33749265150     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20761     Document Type: Article

References (35)

1. Aas T, Borresen AL, Geisler S, Smith-Sorensen B, Johnsen H, Varhaug JE, Akslen LA, Lonning PE. 1996. Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nat Med 2:811-814.
2. Amberg GC, Rossow CF, Navedo MF, Santana LF. 2004. NFATc3 regulates Kv2.1 expression in arterial smooth muscle. J Biol Chem 279:47326-47334.
3. Anzai N, Jutabha P, Kana Y, Endou H. 2005. Integrated physiology of proximal tubular organic anion transport. Curr Opin Nephrol Hypertens 14:472-479.
4. Baudouin-Legros M, Brouillard F, Tondelier D, Hinzpeter A, Edelman A. 2003. Effect of ouabain on CFTR gene expression in human Calu-3 cells. Am J Physiol 284:C620-C626.
5. Borst P, Elferink RO. 2002. Mammalian ABC transporters in health and disease. Annu Rev Biochem 71:537-592.
6. Bremer S, Hoof T, Wilke M, Busche R, Scholte B, Riordan JR, Maass G, Tummler B. 1992. Quantitative expression patterns of multidrug-resistance P-glycoprotein (MDR1) and differentially spliced cystic-fibrosis transmembrane-conductance regulator mRNA transcripts in human epithelia. Eur J Biochem 206:137-149.
7. Breuer W, Slotki IN, Ausiello DA, Cabantchik IZ. 1993. Induction of multidrug resistance downregulates the expression of CFTR in colon epithelial cells. Am J Physiol 265:C1711-C1715.
8. Brown PD, Davies SL, Speake T, Millar ID. 2004. Molecular mechanisms of cerebrospinal fluid production. Neuroscience 129:957-970.
9. Cao L, Owsianik G, Jaspers M, Janssens A, Cuppens H, Cassiman JJ, Nilius B. 2003. Functional analysis of CFTR chloride channel activity in cells with elevated MDR1 expression. Biochem Biophys Res Commun 304:248-252.
10. Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM, Deeley RG. 1992. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258:1650-1654.
11. Han JY, Chung YJ, Park SW, Kim JS, Rhyu MG, Kim HK, Lee KS. 1999. The relationship between cisplatin-induced apoptosis and p53, bcl-2 and bax expression in human lung cancer cells. Korean J Intern Med 14:42-52.
12. Ito K, Suzuki H, Horie T, Sugiyama Y. 2005. Apical/basolateral surface expression of drug transporters and its role in vectorial drug transport. Pharm Res 22:1559-1577.
13. + channels and volume-regulated anion channels in multidrug-resistant small cell lung cancer cells. Cancer Res 53:4156-4160.
14. Kurz EU, Cole SP, Deeley RG. 2001. Identification of DNA-protein interactions in the 5′ flanking and 5′ untranslated regions of the human multidrug resistance protein (MRP1) gene: Evaluation of a putative antioxidant response element/AP-1 binding site. Biochem Biophys Res Commun 285:981-990.
15. Kusuhara H, Sugiyama Y. 2004. Efflux transport systems for organic anions and cations at the blood-CSF barrier. Adv Drug Deliv Rev 56:1741-1763.
16. Latorre R, Oberhauser A, Labarca P, Alvarez O. 1989. Varieties of calcium-activated potassium channels. Annu Rev Physiol 51:385-399.
17. Mackler SA, Eberwine JH. 1994. Cellular adaptation to opiates alters ion-channel mRNA levels. Proc Natl Acad Sci USA 91:385-389.
18. + channels in coronary smooth muscle during aging. Circ Res 88:210-216.
19. Marty A. 1981. Ca-dependent K channels with large unitary conductance in chromaffin cell membranes. Nature 291:497-500.
20. Marty A, Tan YP, Trautmann A. 1984. Three types of calcium-dependent channel in rat lacrimal glands. J Physiol 357:293-325.
21. Maruyama Y, Petersen OH. 1983. Voltage clamp study of stimulant-evoked currents in mouse pancreatic acinar cells. Pflugers Arch 399:54-62.
22. + channel in baso-lateral acinar cell membranes of mammalian salivary glands. Nature 302:827-829.
23. Pancrazio JJ, Viglione MP, Tabbara IA, Kim YI. 1989. Voltage-dependent ion channels in small-cell lung cancer cells. Cancer Res 49:5901-5906.
24. Petersen OH. 1992. Stimulus-secretion coupling: Cytoplasmic calcium signals and the control of ion channels in exocrine acinar cells. J Physiol 448:1-51.
25. + channels in short-term cultured hepatocytes. J Cellular Physiol 171:87-94.
26. + channels of human lung cancer cells. Eur J Pharmacol 435:125-133.
27. Shinoda C, Maruyama M, Fujishita T, Dohkan J, Oda H, Shinoda K, Yamada T, Miyabayashi K, Hayashi R, Kawagishi Y, Fujita T, Matsui S, Sugiyama E, Muraguchi A, Kobayashi M. 2005. Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway. Int J Cancer 117:21-31.
28. Sullivan GF, Yang JM, Vassil A, Yang J, Bash-Babula J, Hait WN. 2000. Regulation of expression of the multidrug resistance protein MRP1 by p53 in human prostate cancer cells. J Clin Invest 105:1261-1267.
29. Trezise AE, Romano PR, Gill DR, Hyde SC, Sepulveda FV, Buchwald M, Higgins CF. 1992. The multidrug resistance and cystic fibrosis genes have complementary patterns of epithelial expression. EMBO J 11:4291-4303.
30. Trezise AE, Ratcliff R, Hawkins TE, Evans MJ, Freeman TC, Romano PR, Higgins CF, Colledge WH. 1997. Co-ordinate regulation of the cystic fibrosis and multidrug resistance genes in cystic fibrosis knockout mice. Hum Mol Genet 6:527-537.
31. Tsang WP, Chau SP, Fung KP, Kong SK, Kwok TT. 2003. Modulation of multidrug resistance-associated protein 1 (MRP1) by p53 mutant in Saos-2 cells. Cancer Chemother Pharmacol 51:161-166.
32. Wang Q, Beck WT. 1998. Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53. Cancer Res 58:5762-5769.
33. + channel alpha subunits in pulmonary artery smooth muscle cells. J Clin Invest 100:2347-2353.
34. Wright SH, Dantzler WH. 2004. Molecular and cellular physiology of renal organic cation and anion transport. Physiol Rev 84:987-1049.
35. + channel activity in pulmonary artery smooth muscle cells. Circulation 104:1557-1563.